-
1
المؤلفون: Helmut Friess, Dirk Waldschmidt, Holger Schulz, Martin Fuchs, Eray Goekkurt, Thomas Geer, Volker Heinemann, Wolfgang Blau, Marcel Reiser, Metin Senkal, Uwe Pelzer, Ralf Jakobs, Michael Stahl, Matthias Egger, Swantje Held, Jens T. Siveke, Ralph Keller, Christina Große-Thie, Thomas J. Ettrich, Stefan Boeck, Hubert J. Stein, Ingo Hartlapp, Georg Maschmeyer, Peter Fix, Thomas Südhoff, U. Lindig, Elke Hennes, Marcus Bahra, Volker Kunzmann, Ingo Klein, Frank Kullmann, Gabriele Margareta Siegler, Christoph Kahl, Hana Algül, Christoph-Thomas Germer, Uwe M. Martens, Stefan Mahlmann
المساهمون: Stahl, Michael (Beitragende*r), Mahlmann, Stefan (Beitragende*r)
مصطلحات موضوعية: Male, FOLFIRINOX, Leucovorin, Medizin, Phases of clinical research, Deoxycytidine, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Aged, 80 and over, education.field_of_study, Induction Chemotherapy, Middle Aged, Neoadjuvant Therapy, Oxaliplatin, Treatment Outcome, 030220 oncology & carcinogenesis, Female, 030211 gastroenterology & hepatology, Fluorouracil, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Paclitaxel, Population, Antineoplastic Agents, Adenocarcinoma, Irinotecan, Drug Administration Schedule, Young Adult, 03 medical and health sciences, Pancreatectomy, Albumins, Internal medicine, medicine, Humans, education, Aged, Neoplasm Staging, Hepatology, business.industry, Induction chemotherapy, medicine.disease, Gemcitabine, Pancreatic Neoplasms, business, Progressive disease, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1066cfe3208263c113f5fd0c464ccbd8Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85099144148Test -
2
المؤلفون: Murielle Mauer, Markus Moehler, Peter C. Thuss-Patience, Uwe M. Martens, Sun Young Rha, Heike I. Grabsch, Anna Dorothea Wagner, Florian Lordick, Carmela Caballero, Lothar Mueller, Annemieke Cats, Yoon-Koo Kang, Masanori Tokunaga, Sandrine Marreaud, Annelie Elme
المساهمون: Pathologie, RS: GROW - R2 - Basic and Translational Cancer Biology
المصدر: BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Cancer, 19:494. BioMed Central Ltd
BMC Cancerمصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Esophageal Neoplasms, Receptor, ErbB-2, SURGERY, medicine.medical_treatment, Gastroenterology, Study Protocol, NEOADJUVANT CHEMOTHERAPY, Antineoplastic Agents, Immunological, 0302 clinical medicine, FOLFOX, Antineoplastic Combined Chemotherapy Protocols, Prospective Studies, OXALIPLATIN, Netherlands, Aged, 80 and over, DOCETAXEL, Middle Aged, OPEN-LABEL, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Chemotherapy regimen, Neoadjuvant Therapy, Progression-Free Survival, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, Gastro-esophageal junction cancer, Esophagogastric Junction, Fluorouracil, Pertuzumab, medicine.drug, Adult, medicine.medical_specialty, Antineoplastic Agents, CAPECITABINE, Adenocarcinoma, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Capecitabine, Young Adult, 03 medical and health sciences, Breast cancer, Stomach Neoplasms, Internal medicine, HER2, Republic of Korea, REGRESSION, Genetics, medicine, Humans, BREAST-CANCER, Perioperative Period, Aged, Cisplatin, Chemotherapy, Perioperative chemotherapy, business.industry, Trastuzumab, medicine.disease, Oxaliplatin, 030104 developmental biology, business, Gastric cancer, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98819406c91ecd11f368ecbad6cc7175Test
https://eprints.whiterose.ac.uk/151178/1/wrro_151178.pdfTest -
3
المؤلفون: Nicole Prasnikar, Stefan Berkhoff, Wolfgang Fischbach, Harald Schmalenberg, Thomas Kraus, Kersten Grimm, Markus Moehler, Matthias Egger, Claudia Pauligk, Salah-Eddin Al-Batran, Uwe M. Martens, Nils Homann, Jörg T. Hartmann, Dirk Arnold, Stephan Probst, Stefan Mönig, Helmut Messmann, Jan Stoehlmacher, Gerald Illerhaus, Ulrich Ronellenfitsch, Elke Jäger, Frank Mayer, Kim Barbara Luley, Michael Koenigsmann, Ralf Hofheinz, Heinz-Gert Höffkes, Stefan Post, Wolf O. Bechstein
المصدر: JAMA oncology, Vol. 3, No 9 (2017) pp. 1237-1244
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAPمصطلحات موضوعية: Cancer Research, Lung Neoplasms, Organoplatinum Compounds, medicine.medical_treatment, Leucovorin, Docetaxel, Gastroesophageal Junction Adenocarcinoma, Lung Neoplasms / drug therapy, Fluorouracil / administration & dosage, 0302 clinical medicine, Quimioterapia Adjuvante, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Medicine, Liver Neoplasms / drug therapy, Prospective Studies, Neoadjuvant therapy, Peritoneal Neoplasms, Original Investigation, Aged, 80 and over, ddc:617, Liver Neoplasms / surgery, Liver Neoplasms, Adenocarcinoma / surgery, Middle Aged, Chemotherapy regimen, Lung Neoplasms / surgery, Neoadjuvant Therapy, Oxaliplatin, Survival Rate, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Lymphatic Metastasis, Adenocarcinoma / drug therapy, 030211 gastroenterology & hepatology, Taxoids, Esophagogastric Junction, Fluorouracil, Metastasectomy, medicine.drug, Peritoneal Neoplasms / surgery, Adult, medicine.medical_specialty, Stomach Neoplasms / drug therapy, Adenocarcinoma, 03 medical and health sciences, Young Adult, Liver Neoplasms / secondary, Peritoneal Neoplasms / drug therapy, Gastrectomy, Stomach Neoplasms, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Neoplasias Gástricas, Humans, Survival rate, Taxoids / administration & dosage, Aged, Neoplasm Staging, Leucovorin / administration & dosage, business.industry, Adenocarcinoma / secondary, Surgery, Organoplatinum Compounds / administration & dosage, Peritoneal Neoplasms / secondary, Lung Neoplasms / secondary, Terapia Neoadjuvante, business, Stomach Neoplasms / pathology, Stomach Neoplasms / surgery
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c3cb2ad6cbae499421eccffe32d5f67Test
https://pubmed.ncbi.nlm.nih.gov/28448662Test -
4
المؤلفون: Uwe M. Martens, Piotr Saramak, Hanno Riess, Stefano Cascinu, Katrin Roth, Wollf Schmiegel, John Bridgewater, Prabhu Rajagopalan, Marc Peeters, Henrik Seidel, Barrett H. Childs, Jean-Luc Van Laethem, Jacek Jassem, Marius Giurescu, Svein Dueland, Bohuslav Melichar, Vittorio Luigi Garosi, Paul Ross, Colin D. Weekes, Patrick Michl, Michael Teufel, Anke Schulz, Alberto Zaniboni, David Van Brummelen, Michael Haas
المساهمون: Van Laethem, J. -L., Riess, H., Jassem, J., Haas, M., Martens, U. M., Weekes, C., Peeters, M., Ross, P., Bridgewater, J., Melichar, B., Cascinu, S., Saramak, P., Michl, P., Van Brummelen, D., Zaniboni, A., Schmiegel, W., Dueland, S., Giurescu, M., Garosi, V. L., Roth, K., Schulz, A., Seidel, H., Rajagopalan, P., Teufel, M., Childs, B. H.
المصدر: Targeted oncology
مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Antimetabolites, Antineoplastic, Bioinformatics, medicine.disease_cause, Deoxycytidine, Disease-Free Survival, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Pancreatic cancer, medicine, Humans, Pharmacology (medical), Sulfonamides, business.industry, Diphenylamine, Middle Aged, medicine.disease, Gemcitabine, Clinical trial, Pancreatic Neoplasms, 030104 developmental biology, Phase i ii, Treatment Outcome, Oncology, chemistry, 030220 oncology & carcinogenesis, Cancer research, Adenocarcinoma, Female, KRAS, Human medicine, business, Refametinib, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb7b5d7aa8ee952eeec33dfc4f153b0aTest
https://hdl.handle.net/10067/1526720151162165141Test -
5
المؤلفون: Jörg Trojan, Matthias Egger, Michael Pohl, Mark Sievert, Timo Gaiser, Dirk Behringer, Elke Jäger, Salah-Eddin Al-Batran, Alfred Königsrainer, Uwe M. Martens, Karel Caca, Michael Heike, Katja Zirlik, Wolfgang Fischbach, Andrea Tannapfel, Gerald Illerhaus, Wolf O. Bechstein, Ulrich Ronellenfitsch, Alexander Reichart, Stephan Probst, Georg Martin Haag, Kim Barbara Luley, Nils Homann, Andreas Block, Sylvie Lorenzen, Peter Schirmacher, Stefan Mönig, Thorsten Oliver Goetze, Martin Schuler, Michael Koenigsmann, Harald Schmalenberg, Wael Hozaeel, Wolff Schmiegel, Hans-Georg Kopp, Ralf Hofheinz, Michael R. Clemens, Claudia Pauligk, Rolf Mahlberg, Johannes Meiler, Nicole Prasnikar
المصدر: Lancet. Oncology, Vol. 17, No 12 (2016) pp. 1697-1708
مصطلحات موضوعية: Male, Esophageal Neoplasms, Leucovorin, Medizin, Docetaxel, Adenocarcinoma / pathology, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Esophageal Neoplasms / pathology, Esophageal Neoplasms / surgery, education.field_of_study, Esophageal Neoplasms / drug therapy, ddc:617, Adenocarcinoma / surgery, Middle Aged, Neoadjuvant Therapy, Oncology, Fluorouracil, 030220 oncology & carcinogenesis, Adenocarcinoma / drug therapy, 030211 gastroenterology & hepatology, Taxoids, Female, Esophagogastric Junction, Cisplatin / administration & dosage, medicine.drug, Epirubicin, Adult, medicine.medical_specialty, Population, Context (language use), Stomach Neoplasms / drug therapy, Adenocarcinoma, Capecitabine, 03 medical and health sciences, Stomach Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, medicine, Humans, education, Aged, Taxoids / administration & dosage, Leucovorin / administration & dosage, business.industry, Interim analysis, Surgery, Oxaliplatin, Cisplatin, business, Stomach Neoplasms / pathology, Epirubicin / administration & dosage, Stomach Neoplasms / surgery
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::782f264dc0eab2317cc3a34935c64c8cTest
https://archive-ouverte.unige.ch/unige:158705Test